|
Volumn 397, Issue , 1998, Pages 301-313
|
The molecular basis for therapeutic concepts utilizing CD14.
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACUTE PHASE PROTEIN;
CARRIER PROTEIN;
CD14 ANTIGEN;
DIHYDROFOLATE REDUCTASE;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
LIPOPOLYSACCHARIDE;
LIPOPOLYSACCHARIDE BINDING PROTEIN;
LIPOPOLYSACCHARIDE-BINDING PROTEIN;
MEMBRANE PROTEIN;
MONOCLONAL ANTIBODY;
ANIMAL;
ARTICLE;
CHEMISTRY;
CHO CELL;
HAMSTER;
HUMAN;
METABOLISM;
MOUSE;
PHYSIOLOGY;
SIGNAL TRANSDUCTION;
STRUCTURE ACTIVITY RELATION;
ACUTE-PHASE PROTEINS;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTIGENS, CD14;
CARRIER PROTEINS;
CHO CELLS;
CRICETINAE;
HUMANS;
LIPOPOLYSACCHARIDES;
MEMBRANE GLYCOPROTEINS;
MICE;
NF-KAPPA B;
SIGNAL TRANSDUCTION;
STRUCTURE-ACTIVITY RELATIONSHIP;
TETRAHYDROFOLATE DEHYDROGENASE;
|
EID: 0031627295
PISSN: 03617742
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (9)
|
References (0)
|